India gives Roche Diagnostics the license to conduct coronavirus tests, looks to delay disease progression

Following the news that the Drug Controller General of India (DCGI) has given license to Roche Diagnostics India to conduct coronavirus tests;

Rohit Anand, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view:

Coronavirus (Covid-19) outbreak has squeezed the imports and countries across the world are rushing to secure additional stocks of test kits. Though India has lagged behind in testing the suspected Covid-19 cases, the country was quick to give Roche Diagnostic India the license to conduct coronavirus tests. India currently imports diagnostic test kits and reagents, and lack domestic manufacturing capabilities.

GlobalData’s research reveals that the Indian in-vitro diagnostics (IVD) market, which accounted for more than 21% of the Asia-Pacific IVD market in 2019, is expected to grow at a compound annual growth rate of 2.5% through 2025.

With Covid-19 cases rising day by day in India, an urgent need for coronavirus diagnostic test kits has arisen. It is never easy to fulfill the demand for a specific test kit to diagnose such a large population and India so far has followed a restricted testing protocol. As a result, the supply of test kits is severely impacted as the demand has surged amid the outbreak.                       

Allowing private companies to use Covid-19 test kits is a smart move by India. In addition, allowing both private and government labs to test patients for Covid-19 was a much needed step at this stage. With India currently in Stage 2 of the outbreak, it is essential for the government to take all precautionary measures to delay the progression to the next stage.”

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roche Sequencing and Life Science. (2020, March 20). India gives Roche Diagnostics the license to conduct coronavirus tests, looks to delay disease progression. News-Medical. Retrieved on June 24, 2024 from https://www.news-medical.net/news/20200320/India-gives-Roche-Diagnostics-the-license-to-conduct-coronavirus-tests-looks-to-delay-disease-progression.aspx.

  • MLA

    Roche Sequencing and Life Science. "India gives Roche Diagnostics the license to conduct coronavirus tests, looks to delay disease progression". News-Medical. 24 June 2024. <https://www.news-medical.net/news/20200320/India-gives-Roche-Diagnostics-the-license-to-conduct-coronavirus-tests-looks-to-delay-disease-progression.aspx>.

  • Chicago

    Roche Sequencing and Life Science. "India gives Roche Diagnostics the license to conduct coronavirus tests, looks to delay disease progression". News-Medical. https://www.news-medical.net/news/20200320/India-gives-Roche-Diagnostics-the-license-to-conduct-coronavirus-tests-looks-to-delay-disease-progression.aspx. (accessed June 24, 2024).

  • Harvard

    Roche Sequencing and Life Science. 2020. India gives Roche Diagnostics the license to conduct coronavirus tests, looks to delay disease progression. News-Medical, viewed 24 June 2024, https://www.news-medical.net/news/20200320/India-gives-Roche-Diagnostics-the-license-to-conduct-coronavirus-tests-looks-to-delay-disease-progression.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Roche launches the cobas EGFR Mutation Test v2 for use with either plasma or tumour tissue samples